Status:
COMPLETED
A Wearable and a Self-management Application for Chronic Obstructive Pulmonary Disease (COPD) Patients at Home
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
University of Toronto
Samsung Electronics
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
40+ years
Brief Summary
Our overall research goal for this project is to create a wearable device and mobile application, appealing to patients with Chronic Obstructive Pulmonary Disease (COPD), which provides them with appr...
Detailed Description
Our overall research goal for this project is to create a wearable device and mobile application, appealing to patients with COPD, which provides them with appropriate self-management tools and detect...
Eligibility Criteria
Inclusion
- Able to speak English
- Moderate to very severe COPD (GOLD C and D) as defined by the GOLD guidelines
- Clinically relevant disease, as defined by a history of exacerbation in the previous 12 months
- Previous spirometry or Pulmonary Function Test results of Forced Expiration Volume/Forced Vital Capacity (FEV1/FVC) \<0.70 with an FEV1 below 80% predicted
- Patient resides at home (not long term care residence or another hospital)
Exclusion
- Pulmonary condition other than COPD as the main respiratory disease such as bronchiectasis or asthma
- Rapid lethal disease, e.g. lung cancer, advance heart failure, end-stage renal disease
- Any medical conditions that would impair their ability to participate in the study
Key Trial Info
Start Date :
June 29 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03857061
Start Date
June 29 2019
End Date
December 30 2023
Last Update
January 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto General Hospital
Toronto, Ontario, Canada, M5G 2C4